Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Inozyme rebrand shows the biopharma in a fresher, purple light | Fierce ...
Inozyme Pharma Announces First Self-Administration of INZ-701 in ...
Inozyme Pharma Announces FDA Fast Track Designation for INZ-701 in ...
INOZYME Tablets GMH Pharmaceuticals Pvt. Ltd.
INOZYME Syrup GMH Pharmaceuticals Pvt. Ltd.
Inozyme Pharma, Inc. - Monteverde & Associates PC
BioMarin to Acquire Inozyme for $270 Million in an All-Cash Tender ...
Inozyme Symposium: From GACI to PXE- The Role of ABCC6 Deficiency: From ...
Inozyme Pharma Acquisition Finalized by BioMarin
Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to ...
Inozyme Pharma Reports First Quarter 2025 Financial Results
Is INZY a Good Value? Inozyme Shares Hit 52-Week Low Despite Positive ...
Inozyme Pharma’s Big Leap: Why INZY Is Surging on BioMarin’s ...
Inozyme Pharma on LinkedIn: #enpp1 #abcc6 #ects2024 #endo2024 #rarediseases
Inozyme Stock: No Major Near-Term Catalysts (NASDAQ:INZY) | Seeking Alpha
Inozyme Pharma on LinkedIn: ‘Do It Or We’re Not Going To Approve Your ...
Inozyme Pharma on LinkedIn: #happythanksgiving
Inozyme Pharma on LinkedIn: #rarediseases #ucispps #ucipharmsci #ucipharmd
Inozyme Pharma on LinkedIn: Our Women in Progress (WIP) team recently ...
Marketing Mix Analysis of Inozyme Pharma, Inc. (INZY) – DCFmodeling.com
Inozyme Pharma Appoints David Thompson, Ph.D., as Senior Vice President ...
BioMarin Completes Strategic Acquisition of Inozyme Pharma - Investors ...
Inozyme Pharma on LinkedIn: #happyholidays #seasonsgreetings
BioMarin's Strategic $270 Million Acquisition of Inozyme Pharma ...
Inozyme Pharma on LinkedIn: #newbornscreening #rarediseases # ...
Inozyme Pharma on LinkedIn: Clinical Trials One-on-One with Catherine ...
Moving the Inozyme Workplace Culture Forward
Inozyme Pharma on LinkedIn: Read more here: https://bit.ly/2kGetFL
Inozyme Pharma on LinkedIn: #raredisease #rarediseaseday
Looking back to look ahead at Inozyme
Inozyme Pharma (INZY) Downgraded by Wells Fargo | INZY Stock New
Inozyme Pharma on LinkedIn: #raredisease #inozyme5 | 10 comments
Inozyme Pharma on LinkedIn: #raredisease #onerarevoice | 10 comments
Inozyme Pharma on LinkedIn: #biotech #biopharmaceutical
Meet Janine - Inozyme
Inozyme Pharma on LinkedIn: Inozyme Pharma announced the authorization ...
Inozyme Pharma on LinkedIn: #enpp1 #ects2023 #biotech #biopharmaceutical
Why Did Inozyme Pharma, Inc. (INZY) Get a Strong Buy Rating from ...
INOZYME 100ML, Non prescription at ₹ 99/bottle in Chandigarh | ID ...
Inozyme urges Congress to reauthorize PRV program | Inozyme Pharma ...
Inozyme Pharma reports promising initial results from ongoing INZ-701 ...
BioMarin’s Bold Move in Rare Diseases: How the Inozyme Deal Unlocks a ...
Inozyme Pharma on LinkedIn: #raredisease #biotech
Inozyme Pharma on LinkedIn: #gaci #arh2 #biotechbattle #biotech #charity
Inozyme Pharma on LinkedIn: #gaci #abcc6 #raredisease #rarediseases # ...
Inozyme Pharma on LinkedIn: #newbornscreening #rarediseases #enpp1 # ...
Our Science - Inozyme
Inozyme Pharma on LinkedIn: #ABCC6 #ENPP1 #Inozyme5
Inozyme Pharma on LinkedIn: #companyculture
Inozyme Pharma on LinkedIn: #enpp1 #raredisease
Inozyme Pharma on LinkedIn: #enpp1
Inozyme Pharma on LinkedIn: #inspireinclusion #inozymewip #womenserg # ...
A number of insiders bought Inozyme Pharma, Inc. (NASDAQ:INZY) stock ...
Wells Fargo Downgrades Inozyme Pharma (INZY)
Inozyme Pharma on LinkedIn: #raredisease #biotech #biopharmaceutical
BioMarin agrees to acquire Inozyme for $270m
Inozyme Pharma on LinkedIn: #gaci #enpp1 #newbornscreening # ...
Wedbush Maintains Inozyme Pharma (INZY) Outperform Recommendation | Nasdaq
We're pleased to announce that Inozyme Pharma is now a wholly owned ...
Inozyme Pharma on LinkedIn: #enpp1 #abcc6 #asbmr2023 #rarediseases # ...
Inozyme Employee Perks & Benefits | Levels.fyi
Inozyme Pharma on LinkedIn: #asn #kidneyweek
Inozyme Pharma (INZY) Investor Presentation - Slideshow (NASDAQ:INZY ...
Positive Topline Data for Inozyme Pharma - PRISM MarketView
Inozyme Pharma on LinkedIn: #enpp1 #abcc6 #rarediseases #biotech # ...
Inozyme Pharma on LinkedIn: #enpp1 #abcc6 #pedsendo2023 #ece2023
Inozyme Pharma on LinkedIn: #enpp1 #iccbh2024
FDA Grants Fast Track Designation to Inozyme Pharma’s INZ-701, a ...
BioMarin Acquires Inozyme for $270M to Expand Rare Disease Pipeline ...
Inozyme Pharma on LinkedIn: #icymi #biotech #raredisease # ...
Inozyme Pharma on LinkedIn: #inozyme5 #biotech #biopharmaceutical # ...
Inozyme Pharma on LinkedIn: #gaci #wcpccs2023 #inac2023 #jenscongress # ...
Inozyme Pharma on LinkedIn: #rarediseases #asbmr2024
Inozyme Pharma logo in transparent PNG and vectorized SVG formats
Inozyme Pharma on LinkedIn: Last week we announced our founding CEO ...
#rarediseaseday | Inozyme Pharma
Inozyme Pharma on LinkedIn: #newbornscreening #rarediseases #gaci #enpp1
InoZyme By Prime Health Pharmaceutical - Thailand Best Selling Beauty ...
Inozyme Pharma on LinkedIn: #gaci #raredisease
Inozyme Targets Underserved Mineralization Disorders Market With First ...
Inozyme Pharma on LinkedIn: #enpp1 #enpp1 #raredisease # ...
Inozyme Pharma on LinkedIn: #ashgforum #enpp1 #ashg22 #biotech # ...
Inozyme Pharma on LinkedIn: #abcc6 #rarediseases # ...
Inozyme Pharma hires chief medical officer - People Moves
BioMarin Bolsters Its Pipeline With $270 Million Inozyme Buyout ...
How Inozyme Pharma solved quality challenges | ZenQMS posted on the ...
Congratulations to Inozyme Pharma and King Faisal Specialist Hospital ...
Inozyme Pharma on LinkedIn: #rarediseases #enpp1 #abcc6 # ...
Inozyme Pharma on LinkedIn: #rarediseases #pridemonth #inclusivity # ...
Inozyme Pharma on LinkedIn: #newbornscreening #enpp1 #abcc6 #smfm2023 # ...
Inozyme Pharma on LinkedIn: #enpp1 #abcc6 | 19 comments
Interview with the Chairman and CEO: Inozyme Pharma Inc. (NASDAQ:INZY ...
Inozyme Pharma on LinkedIn: #healthcareconference
Inozyme Pharma on LinkedIn: #enpp1 #abcc6
Healthcare Professionals - Inozyme
Inozyme Pharma Announces JBMR Plus Publication
Inozyme Pharma on LinkedIn: #abcc6 #enpp1 #gaci
Inozyme Pharma on LinkedIn: #enpp1 #abcc6 #biotech #biopharmaceutical
StockWatch: With Inozyme Buyout, BioMarin Pursues Growth via M&A
Inozyme Pharma on LinkedIn: #biotech #biopharmaecutical
Inozyme Pharma Stock Soars 178.17% on BioMarin Acquisition
Inozyme Pharma on Twitter: "Our team is looking forward to attending ...
Inozyme Pharma on LinkedIn: #enpp1 #healthcareconference
Home | Inozyme Pharma
Inozyme Pharma (INZY) Soars 33.88% on Positive Drug Data
Inozyme Pharma Announces Positive Topline Data from Ongoing Phase 1/2 ...
#inozyme #raredisease #enpp1 #abcc6 | INAC - International Neonatology ...
The Best Pharmaceutical Website Design Examples of 2024 | Deploi
#worldkidneyday #calciphylaxis #raredisease #kidneyhealthforall # ...
Inozyme: Q4 Of 2024 Phase 1 INZ-701 Data Could Lead To Indication ...
Inozyme: Several Catalysts To Move Rare Disease Pipeline Programs ...
Endpoints Unzipped: Inozyme's INZ-701 Twist In The Plot (NASDAQ:INZY ...
Deal Adds to Our Enzyme Therapies Business Unit Skeletal ...
